Literature DB >> 9115266

Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder.

A M Cole1, P Weis, G Diamond.   

Abstract

Antimicrobial peptides are found in both myeloid cells and mucosal tissues of many vertebrates and invertebrates. These peptides are predicted to operate as a first-line host defense mechanism exerting broad-spectrum activity against pathogenic bacteria, fungi, parasites, and enveloped viruses. We report the characterization of a novel 25-residue linear antimicrobial peptide found in the skin mucous secretions of the winter flounder (Pleuronectes americanus). This peptide was purified through multiple chromatographic methods to obtain a single peak by reversed-phase high performance liquid chromatography. This purified peptide, which we named pleurocidin, exhibited antimicrobial activity against Escherichia coli in a bacterial cell lysis plate assay. Mass spectrometry and amino acid sequence analysis indicated that it is 25 amino acids in length. Pleurocidin is predicted to assume an amphipathic alpha-helical conformation similar to many other linear antimicrobial peptides. There is a high degree of homology between pleurocidin and two antimicrobial peptides, ceratotoxin from the Mediterranean fruit fly and dermaseptin from the skin of a hylid frog. The minimal inhibitory concentration and minimal bactericidal concentration of pleurocidin were determined against 11 different Gram-negative and Gram-positive bacteria. Immunohistochemistry locates pleurocidin in the epithelial mucous cells of flounder skin. Pleurocidin represents a novel antimicrobial peptide found in fish and may play a role in innate host defense.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115266     DOI: 10.1074/jbc.272.18.12008

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  86 in total

Review 1.  Fish can be first--advances in fish transgenesis for commercial applications.

Authors:  Halina M Zbikowska
Journal:  Transgenic Res       Date:  2003-08       Impact factor: 2.788

Review 2.  Nonmammalian vertebrate antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 3.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  Enhanced synonymous site divergence in positively selected vertebrate antimicrobial peptide genes.

Authors:  Jacob A Tennessen
Journal:  J Mol Evol       Date:  2005-09-12       Impact factor: 2.395

Review 5.  The continuing story of class IIa bacteriocins.

Authors:  Djamel Drider; Gunnar Fimland; Yann Héchard; Lynn M McMullen; Hervé Prévost
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

6.  Molecular dynamics investigation of the influence of anionic and zwitterionic interfaces on antimicrobial peptides' structure: implications for peptide toxicity and activity.

Authors:  Himanshu Khandelia; Yiannis N Kaznessis
Journal:  Peptides       Date:  2005-12-01       Impact factor: 3.750

7.  Molecular cloning of cecropin B responsive endonucleases in Yersinia ruckeri.

Authors:  Ulysses W Sallum; Thomas T Chen
Journal:  Mar Biotechnol (NY)       Date:  2010-03-30       Impact factor: 3.619

8.  Zwitterionic phospholipids and sterols modulate antimicrobial peptide-induced membrane destabilization.

Authors:  A James Mason; Arnaud Marquette; Burkhard Bechinger
Journal:  Biophys J       Date:  2007-08-31       Impact factor: 4.033

9.  Anti-microbial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss.

Authors:  Jorge M O Fernandes; Graham D Kemp; M Gerard Molle; Valerie J Smith
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

Review 10.  The roles of antimicrobial peptides in innate host defense.

Authors:  Gill Diamond; Nicholas Beckloff; Aaron Weinberg; Kevin O Kisich
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.